CCL2 and chronic kidney disease: The increase of these biomarkers after 10h, more intense in bleeding patients, may reveal tubular maladaptive repair, consistent with animal studies (Zheng et al., 2021), exacerbated by renal inflammation via biomarkers, such as MCP-1 production, which could contribute to AKI-CKD transition.